Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Apixaban 2.5 mg film-coated tablets

Active Ingredient:
apixaban
Company:  
axunio Pharma GmbH See contact details
ATC code: 
B01AF02
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Apixaban Prescriber Guide

{healthcare_pro_orange} For Healthcare Professionals

The educational pack is aimed at increasing awareness about the potential risk of bleeding/bleeding or thrombosis due to overdose or underdose during treatment with apixaban and providing guidance on how to manage that risk. This Prescriber Guide is not a substitute for the Apixaban Summary of Product Characteristics (SmPC). Please consult the SmPC for full prescribing information.

{pdf_link}

Patient Alert Card

The patient alert card is aimed at increasing awareness about the potential risk of bleeding during treatment with apixaban. Patients prescribed apixaban will receive a patient alert card in the medicinal pack with the package leaflet. Please carry the patient alert card with you at all times and show it to every healthcare professional including pharmacists.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

axunio Pharma GmbH
Company image
Address
Van-der-Smissen-Strasse 1, Hamburg, 22767, Germany
WWW
https://axunio.eu/
Telephone
+ 49 (0)40 - 38 02 32 14
Fax
+ 49 (0)40 - 38 02 32 09
Medical Information Direct Line
+ 49 (0)40 - 38 02 32 14
Medical Information e-mail
[email protected]
Customer Care direct line
+ 49 (0)40 - 38 02 32 14
Stock Availability
[email protected]